Long-Term Care After COVID-19:
Patients, Prescriptions, and Public Policy
Featuring Alan Rosenbloom, President & CEO of the Senior Care Pharmacy Coalition
People who need long-term care and services – primarily seniors and younger disabled adults – have always preferred remaining at home to entering a LTC facility. In many cases, services and resources are not available in the community, particularly for those who require assistance from government to obtain long-term care services and support. Despite growing recognition of the value offered by community-based and transition LTC services, government programs – primarily Medicare and Medicaid – have been slow to expand community-based options since the 1990s.
Before the COVID-19 pandemic, the balance began tipping away from facility-based care, and LTC pharmacies have begun to seize the opportunities offered as more LTC patients were remaining at or returning to home. Once the pandemic abates, the LTC market could reorient toward greater home-based care.
Special guest Alan Rosenbloom discussed the drivers of the shift to greater reliance on LTC-at-home, the opportunities and risks this shift presents for LTC pharmacies, and the degree to which federal public policy may create opportunities or obstacles to thrive in the changing marketplace.
Session Objectives:
- Identify market and public policy trends driving growth in home-and-community based LTC services and supports
- Recognize the implications of COVID-19 on the future of current LTC pharmacy business models
- Define market opportunities and federal policy imperatives for the future
This live webinar has passed, to watch the recording simply fill out the form to the right for immediate access.
Speaker:
Alan Rosenbloom
President & CEO
Senior Care Pharmacy Coalition (SCPC)
Full Bio:
Alan G. Rosenbloom serves as President & CEO of the Senior Care Pharmacy Coalition (SCPC), the only trade group in Washington dedicated exclusively to the political and public policy interests of long-term care pharmacies. He helped a small group of pharmacies to create the SCPC in October 2014. During his tenure, SCPC assured that legislation to address the opioid crisis recognized the unique characteristics of the LTC patient population and appropriate application to LTC pharmacies, supported market efforts to improve payments and reduce administrative burdens for LTC pharmacies under Medicare Part D and persuaded the FDA to modify regulatory requirements that would have undermined care for patients in LTC facilities. Since founding SCPC in 2014, Alan has more than quintupled both membership and revenues. SCPC represents more than 400 LTC pharmacies caring for more than 850,000 residents in nursing homes and other LTC settings across in all 50 states.
Alan has spent his entire professional career in health care, including stints as President of the Alliance for Quality Nursing Home Care, President and CEO of the Pennsylvania Health Care Association and Acting President, Executive Vice President and Chief Operating Officer of LeadingAge. He began his career as a health care lawyer in Philadelphia, with a particular focus on representing long term providers.
Alan received a Juris Doctor from the University of Pennsylvania, where he served as Associate Editor of The Law Review and also studied public policy at the Wharton School. He received his undergraduate degree from the University of Massachusetts, graduating summa cum laude with a degree in English literature.